Apply for Promacta (Eltrombopag) Copay Assistance Now

Promacta (eltrombopag) is a thrombopoietin receptor agonist that stimulates bone marrow to produce more platelets. According to FDA prescribing information, Promacta is approved to treat:

• Chronic immune thrombocytopenia (ITP) in adults and children 1 year and older who have had an insufficient response to corticosteroids, immunoglobulins, or splenectomy
• Thrombocytopenia in patients with chronic hepatitis C infection to allow initiation and maintenance of interferon-based therapy
• Severe aplastic anemia in combination with standard immunosuppressive therapy in patients who have had an insufficient response to immunosuppressive therapy alone
• Severe aplastic anemia as a single agent in patients refractory to at least one prior immunosuppressive therapy

QuickRx Specialty Pharmacy dispenses both brand-name Promacta and FDA-approved generic eltrombopag, helping patients access whichever version their insurance covers or provides the greatest savings.

Eltrombopag is the generic name for Promacta. Both contain the identical active ingredient and work the same way in your body to stimulate platelet production.

Key differences:

• Cost: Generic eltrombopag typically has lower baseline costs than brand-name Promacta
• Appearance: Tablets may look different but contain the same medicine
• Manufacturer: Brand-name Promacta is manufactured by Novartis, while generic eltrombopag is produced by various FDA-approved manufacturers including Teva Pharmaceuticals (Alvaiz)
• Insurance coverage: Some insurance plans require or prefer the generic version
• Copay assistance: Different copay card programs may be available for brand vs. generic

Both medications are equally effective when taken as prescribed. QuickRx helps you access Promacta copay card programs or eltrombopag copay assistance based on which option offers the best savings for your situation.

Promacta (eltrombopag) works by binding to and activating the thrombopoietin (TPO) receptor on bone marrow cells. This stimulates the production and differentiation of megakaryocytes—large cells in the bone marrow that produce platelets.

Unlike treatments that simply prevent platelet destruction, Promacta addresses low platelet counts by helping your body make more platelets. According to clinical research published in StatPearls, eltrombopag is a small-molecule thrombopoietin receptor agonist that works differently than recombinant thrombopoietin proteins, offering an oral treatment option for patients with thrombocytopenia.

Promacta (eltrombopag) is available in several formulations to meet different patient needs:

Tablets:

• 12.5 mg tablets
• 25 mg tablets
• 50 mg tablets
• 75 mg tablets

Oral suspension packets:

• 12.5 mg packets
• 25 mg packets

The oral suspension is particularly useful for pediatric patients or adults who have difficulty swallowing tablets. Your healthcare provider will determine the appropriate starting dose based on your platelet count, diagnosis, and other factors. QuickRx pharmacists can provide guidance on proper preparation and administration of either formulation.

Proper administration is essential for Promacta (eltrombopag) to work effectively. Follow these important guidelines:

• Take on an empty stomach: At least 1 hour before or 2 hours after eating
• Avoid calcium-rich foods: Do not take with dairy products, calcium-fortified foods, or calcium supplements—these significantly reduce absorption
• Separate from antacids and minerals: Take antacids, iron supplements, or mineral supplements at least 4 hours before or 2 hours after your Promacta dose
• If using oral suspension: Mix with water only (not hot water), stir, and drink within 30 minutes
• Take consistently: Same time each day as directed by your healthcare provider

Your QuickRx pharmacist can provide personalized guidance on how to incorporate Promacta into your daily routine while avoiding food and drug interactions.

Like all medications, Promacta (eltrombopag) may cause side effects. Understanding what to expect helps you work with your healthcare team to manage them effectively.

Common side effects (reported in 5% or more of patients):

• Nausea and diarrhea
• Upper respiratory tract infection
• Headache and fatigue
• Cough and fever
• Back pain and muscle aches
• Pain in extremities
• Insomnia

Serious side effects requiring immediate medical attention:

• Liver problems (hepatotoxicity): Yellowing of skin/eyes, dark urine, upper right abdominal pain
• Blood clots: Deep vein thrombosis, pulmonary embolism, stroke
• Cataracts: Vision changes, cloudy or blurred vision
• Bone marrow changes: Reticulin fiber formation (monitored through bone marrow exams)

QuickRx pharmacists are available 24/7 to answer questions about Promacta side effects and help you understand when to contact your healthcare provider.

Patients taking Promacta (eltrombopag) require regular monitoring to ensure safe and effective treatment:

Blood tests:

• Platelet counts: Weekly during dose adjustment, then monthly once stable
• Liver function tests (ALT, AST, bilirubin): Before starting, every 2 weeks during dose adjustment, then monthly
• Complete blood count: To monitor for changes in other blood cell lines

Other monitoring:

• Eye examinations: Baseline and regular monitoring for cataracts, especially during long-term use
• Peripheral blood smear: To check for abnormal blood cell shapes
• Bone marrow examination: May be required in certain situations per your hematologist

QuickRx coordinates with your healthcare team to ensure all necessary monitoring is completed and helps schedule refills around your lab appointments.

Promacta (eltrombopag) can interact with several medications and supplements. According to drug interaction databases, important interactions include:

Medications that affect Promacta absorption (take 4 hours apart):

• Antacids containing aluminum, calcium, or magnesium
• Iron supplements
• Mineral supplements (calcium, magnesium, aluminum, selenium, zinc)

Medications whose levels may be affected by Promacta:

• Statins (rosuvastatin, atorvastatin, pravastatin, simvastatin)
• Certain chemotherapy agents
• Methotrexate
• Some antibiotics (ciprofloxacin)

Always inform your healthcare provider and pharmacist about all medications, supplements, and herbal products you take. Your QuickRx pharmacist will conduct a thorough review of your medication profile to identify potential interactions and provide guidance on how to manage them safely.

If you miss a dose of Promacta (eltrombopag):

• Take it as soon as you remember on that same day
• Return to your regular dosing schedule the next day
• Do NOT take two doses on the same day to make up for a missed dose

Consistent dosing helps maintain stable platelet levels. If you frequently forget doses, talk to your QuickRx pharmacist about strategies for medication adherence, including refill reminders and dosing schedules.

Treatment duration with Promacta (eltrombopag) varies depending on your specific condition:

• Chronic ITP: Treatment is typically ongoing for as long as clinically appropriate, as ITP is a chronic condition requiring long-term management
• Hepatitis C-related thrombocytopenia: Usually continued throughout antiviral treatment to maintain adequate platelet levels for interferon therapy
• Severe aplastic anemia: Duration varies based on treatment response; some patients may eventually taper off while others require long-term therapy

Your hematologist will regularly evaluate your response and determine the optimal treatment duration. QuickRx ensures uninterrupted access to Promacta through proactive refill coordination and continuous copay assistance monitoring.

The safety of Promacta (eltrombopag) during pregnancy and breastfeeding has not been well-established. According to LactMed and prescribing information:

• Animal studies have shown adverse effects on fetal development
• No adequate, well-controlled studies exist in pregnant women
• It is unknown whether eltrombopag passes into breast milk
• A pregnancy exposure registry exists to collect outcomes data

If you are pregnant, planning to become pregnant, or breastfeeding, discuss the potential risks and benefits with your healthcare provider before starting or continuing Promacta treatment. Your healthcare team will help weigh the benefits of treatment against potential risks.

A Promacta copay card is a manufacturer-sponsored program that reduces your out-of-pocket costs at the pharmacy. These programs are available for both brand-name Promacta and generic eltrombopag from certain manufacturers.

How the Promacta copay card works:

1. You present your copay card along with your insurance card at the pharmacy
2. Your insurance is billed first and determines your copay/coinsurance amount
3. The copay card covers the difference between your insurance copay and a lower amount
4. Eligible patients may pay $0 for their Promacta prescription

QuickRx handles the entire Promacta copay card enrollment process at no cost to you. We ensure your copay assistance is applied correctly to every fill and monitor your benefits to prevent any gaps in coverage.

Eligibility for Promacta copay assistance depends on your insurance type and specific program requirements:

Commercially insured patients:

• Active commercial (private) health insurance that covers Promacta or eltrombopag
• Valid prescription from a licensed healthcare provider
• U.S. or Puerto Rico residency
• NOT enrolled in Medicare, Medicaid, TRICARE, VA, or other government-funded programs

Medicare and Medicaid patients:

• Cannot use manufacturer copay cards due to federal Anti-Kickback regulations
• May qualify for independent foundation grants (income-based eligibility)
• QuickRx connects eligible patients to foundation programs for hematology medications

Uninsured patients:

• May qualify for manufacturer patient assistance programs providing free medication
• Income limits typically 400-500% of federal poverty level
• Annual application required with income documentation

QuickRx evaluates your specific situation and identifies every Promacta copay assistance program you qualify for.

Getting started with Promacta copay assistance is simple:

Step 1: Contact QuickRx
Call (917) 830-2525 or toll-free (800) 496-6111, or complete our online enrollment form above.

Step 2: Benefits Verification
A QuickRx specialist will verify your insurance benefits and identify all available Promacta copay card and patient assistance programs you qualify for.

Step 3: Enrollment
We handle the entire application process—no paperwork hassles for you. Most patients are enrolled within 24-48 hours.

Step 4: Ongoing Support
Once enrolled, QuickRx monitors your benefits continuously, coordinates refills, arranges nationwide home delivery, and ensures you never experience a surprise lapse in Promacta copay assistance coverage.

QuickRx Specialty Pharmacy provides comprehensive support for patients on complex hematology medications like Promacta:

• ACHC-Accredited & URAC-Accredited: QuickRx maintains the highest standards for specialty pharmacy services
• Hematology expertise: Our pharmacists specialize in ITP, aplastic anemia, and blood disorder medications
• Complete copay assistance coordination: We identify and enroll you in every program you qualify for
• Insurance navigation: Prior authorization support, benefits verification, and appeals assistance
• Nationwide home delivery: Licensed in all 50 states with temperature-controlled shipping
• 24/7 pharmacist access: Questions answered any time, day or night
• Proactive refill management: We contact you before you run out of medication
• Continuous benefits monitoring: We ensure your Promacta copay card never lapses

Contact QuickRx today at (917) 830-2525 to learn how we can help reduce your Promacta costs.

References

1. U.S. Food and Drug Administration. Promacta (eltrombopag) Prescribing Information. Novartis Pharmaceuticals Corporation.
2. National Institutes of Health. Eltrombopag. StatPearls Publishing.
3. U.S. Food and Drug Administration. FDA Approves Eltrombopag for First-Line Treatment of Severe Aplastic Anemia.
4. National Library of Medicine. DailyMed: Promacta Drug Label.
5. National Library of Medicine. LactMed: Eltrombopag. Drugs and Lactation Database.
6. Platelet Disorder Support Association. ITP Patient Resources.
7. Aplastic Anemia & MDS International Foundation. Patient Education and Support.